Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-05-2146PMID 16380454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chapter 53. Cytomegalovirus Infection

  2007cited by this paper
• Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.

  2005influential reference
• Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

  2005influential reference
• Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

  2005cited by this paper
• Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.

  2004influential reference
• Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance

  2004cited by this paper
• Survival Analysis: Techniques for Censored and Truncated Data

  2004influential reference
• Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

  2004influential reference
• Non-T-Cell-Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation From a Family Donor Based on Fetomaternal Microchimerism in Pediatric Hematologic Malignancies

  2004influential reference
• Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

  2004influential reference
• CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation

  2004influential reference
• Graft engineering for allogeneic haploidentical stem cell transplantation.

  2004influential reference
• Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

  2004influential reference
• Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.

  2004influential reference
• Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells.

  2004cited by this paper
• Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.

  2003influential reference
• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissio

  2003influential reference
• Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.

  2003influential reference
• Influence of Anti-Thymocyte Globulin As Part of the Conditioning Regimen on Immune Reconstitution Following Matched Related Bone Marrow Transplantation

  2003influential reference
• Immunsuppressive Protokolle

  2002influential reference
• G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia

  2002influential reference
• Correlation of Vascular Endothelial Growth Factor-C Expression with Tumor-Infiltrating Dendritic Cells in Gastric Cancer

  2002cited by this paper
• Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis

  2002influential reference
• Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

  2002influential reference
• Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

  2001cited by this paper
• Adenovirus infections in adult recipients of blood and marrow transplants.

  2001influential reference
• Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts

  2001cited by this paper
• G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.

  2000influential reference
• Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

  2000influential reference
• Transplantation of Megadoses of Purified Haploidentical Stem Cells

  1999influential reference
• Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment

  1999influential reference
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999influential reference
• Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients.

  1998influential reference
• Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood.

  1997cited by this paper
• Use of stem cells from mismatched related donors

  1997influential reference
• A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF

  1997influential reference
• Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.

  1996influential reference
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996influential reference
• Transplantation of CD34+ hematopoietic progenitor cells.

  1996influential reference
• The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man.

  1996influential reference
• Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.

  1995cited by this paper
• Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation.

  1995influential reference
• Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

  1995cited by this paper
• Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.

  1995influential reference
• Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide.

  1994influential reference
• Transplantation of CD34+ Hematopoietic Progenitor Cells*

  1994cited by this paper
• THE FREQUENCY OF PRETRANSPLANT DONOR CYTOTOXIC T CELL PRECURSORS WITH ANTI‐HOST SPECIFICITY PREDICTS SURVIVAL OF PATIENTS TRANSPLANTED WITH BONE MARROW FROM DONORS OTHER THAN HLA‐IDENTICAL SIBLINGS

  1993influential reference
• Cytokine dysregulation and acute graft-versus-host disease.

  1992influential reference
• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  1991influential reference
• HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: Stable immunological reconstitution and reversal of skeletal abnormalities

  1989influential reference
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987influential reference
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980influential reference
• Bone marrow transplantation for severe aplastic anemia. A report of 9 cases.

  1979cited by this paper
• Bone Marrow Transplantation for Severe Aplastic Anemia

  1979cited by this paper
• Bone marrow transplantation.

  1977influential reference
• Bone-marrow transplantation (second of two parts).

  1975cited by this paper

• Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and Survival.

  2026cites this paper
• Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation.

  2026cites this paper
• Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodies.

  2026cites this paper
• Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

  2026cites this paper
• Blinatumomab exposure prior to allogeneic stem cell transplantation is associated with increased Epstein-Barr virus reactivation

  2026cites this paper
• Equivalent incidences of paediatric graft‐versus‐host disease regardless of donor–recipient matching in the era of modern prophylaxis agents

  2025cites this paper
• Fine-tuning of haploidentical haematopoietic stem cell transplantation.

  2025cites this paper
• Clinical and Economic Burden of Cytomegalovirus (CMV) Infection/Disease Among Hospitalized Adult Allogeneic Hematopoietic Stem Cell Transplant (Allo‐HSCT) Recipients in China

  2025cites this paper
• Thrombotic thrombocytopenic purpura following allogeneic haematopoietic stem cell transplantation: a rare but fatal complication.

  2025cites this paper
• Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non‐T‐Cell Depletion Protocols

  2025cites this paper
• PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation

  2025cites this paper
• 造血干细胞移植在急性髓系白血病中的应用进展

  2025cites this paper
• Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee

  2025cites this paper
• Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis

  2025cites this paper
• Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomes

  2025cites this paper
• Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study.

  2025cites this paper
• Comparable Survival Outcomes in HLA-Matched and Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Patients Aged 40-50: A CBMTR Registry-Based Propensity Score Matching Analysis Over the Last Decade.

  2025cites this paper
• Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a‐rearranged acute myeloid leukemia

  2025cites this paper
• Exploration of In Vivo T-cell Depletion protocols in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

  2025cites this paper
• Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity

  2025cites this paper
• Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

  2025cites this paper
• Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation

  2025cites this paper
• Individualized rabbit anti‐thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high‐risk hematologic malignancy: Exposure–response analysis and population pharmacokinetics simulations

  2024cites this paper
• A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation

  2024cites this paper
• Clinical characteristics of membranous nephropathy after allogeneic hematopoietic stem cell transplantation: A real-world multicenter study

  2024cites this paper
• Similar Survival But Less Chronic GVHD in Antithymocyte Globulin–Based Myeloablative Haploidentical Transplant Compared With Matched Sibling Transplant for Adult T-cell Acute Lymphoblastic Leukemia/Lymphoma

  2024cites this paper
• Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.

  2024cites this paper
• Recent advancements in hematopoietic stem cell transplantation in Taiwan

  2024cites this paper
• Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

  2024cites this paper
• Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies

  2024cites this paper
• HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis

  2024cites this paper
• Risk Factors of Cytomegalovirus Retinitis Occurrence After Allogeneic Hematopoietic Stem Cell Transplantation

  2024cites this paper
• Pediatric adapted risk index to predict 2-year transplant-related mortality post-HSCT in children

  2024cites this paper
• Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation

  2024cites this paper
• 单倍体造血干细胞移植模式下供者HLA-Bw4对移植后NK细胞重建及移植相关死亡风险的影响

  2024cites this paper
• Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival

  2024cites this paper
• Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia

  2024cites this paper
• Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study

  2024cites this paper
• Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation

  2024cites this paper
• Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study

  2023cites this paper
• DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML

  2023cites this paper
• Targeting TFH cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an in vitro and in vivo study

  2023cites this paper
• Targeted dosing of anti‐thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single‐arm, phase 2 trial

  2023cites this paper
• Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission

  2023cites this paper
• Effectiveness of in vivo T‐cell‐depleted regimen containing porcine anti‐lymphocyte globulin or rabbit anti‐thymocyte globulin in preventing acute graft‐versus‐host disease after haploidentical haematopoietic stem cell transplantation

  2023cites this paper
• Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis

  2023cites this paper
• Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial

  2023cites this paper
• Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia

  2023cites this paper
• Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study

  2023cites this paper
• CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation

  2023cites this paper
• A prognostic model based on clinical biomarkers for heart failure in adult patients following allogeneic hematopoietic stem cell transplantation.

  2023cites this paper
• Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients

  2023cites this paper
• Peritransplant glucocorticoid haploidentical stem cell transplantation is a promising strategy for AML patients with high leukemic burden: Comparison with transplants using other donor types.

  2023cites this paper
• 两种扩增体系NK细胞生物学特性比较及治疗异基因造血干细胞移植后白血病复发的初步研究

  2022cites this paper
• Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience.

  2022cites this paper
• Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

  2022cites this paper
• Decoding lymphomyeloid divergence and immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq

  2022cites this paper
• Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry

  2022cites this paper
• Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation

  2022cites this paper
• A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation

  2022cites this paper
• Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit vs Matched Related Transplants

  2022cites this paper
• Case Report: Metagenomic Next-Generation Sequencing Can Contribute to the Diagnosis and Treatment of Disseminated Visceral Kaposi Sarcoma Following Allogeneic Haematopoietic Stem Cell Transplantation

  2022cites this paper
• Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

  2022cites this paper
• Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data

  2022cites this paper
• Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation

  2022cites this paper
• Adoptive therapy with cytomegalovirus‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

  2022cites this paper
• Clinical study of late-onset hemorrhagic cystitis after allo-HSCT without in vitro T-cell depletion

  2022cites this paper
• Association between CD34+ and CD3+ T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation: A single-center study.

  2022cites this paper
• A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors—A single‐centre, prospective, explorative study

  2022cites this paper
• Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions.

  2022cites this paper
• Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment

  2022cites this paper
• Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-versus-host disease in pediatric patients with acquired severe aplastic anemia

  2022cites this paper
• Risk stratification system for skin and soft tissue infections after allogeneic hematopoietic stem cell transplantation: PAH risk score

  2022cites this paper
• HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis

  2022cites this paper
• Allogreffe de cellules souches hématopoïétiques à partir d’un donneur haplo-identique*

  2022cites this paper
• Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

  2022cites this paper
• Effects of CD34+ cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease

  2022cites this paper
• Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients.

  2022cites this paper
• Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies

  2022cites this paper
• Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia

  2022cites this paper
• Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.

  2022cites this paper
• Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

  2021cites this paper
• Which is better, HLA-matched sibling or haploidentical transplantation?

  2021cites this paper
• Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.

  2021cites this paper
• A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation

  2021cites this paper
• Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy

  2021cites this paper
• Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation

  2021cites this paper
• Acute Cholecystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Features, Outcomes, Risk Factors, and Prediction Model.

  2021cites this paper
• A scoring system for predicting the prognosis of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation.

  2021cites this paper
• Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience.

  2021cites this paper
• Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

  2021cites this paper
• 儿童异基因造血干细胞移植后BK病毒脑炎临床研究

  2021cites this paper
• Unmanipulated haploidentical donor and matched unrelated donor hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study

  2021cites this paper
• Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein–Barr virus infection: a retrospective analysis of a single center

  2021cites this paper
• Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study

  2021cites this paper
• Effect of late-onset hemorrhagic cystitis on PFS after haplo-PBSCT

  2021cites this paper
• Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia

  2021cites this paper
• Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective

  2021cites this paper
• Comparison of 2 Different Doses of Antithymocyte Globulin in Conditioning Regimens for Haploidentical Hematopoietic Stem Cell Transplantation.

  2021cites this paper